Endocrinology Advisor
250 FOLLOWERS
Endocrinology Advisor is an online resource that provides health care professionals with comprehensive information on important principles of care in endocrinology as well as up-to-date clinical news on the diagnosis and treatment of endocrine conditions.
Endocrinology Advisor
57m ago
COVID-19 infection is associated with an increased risk for thyroid dysfunction during 1-year follow-up, according to results of a study published in Thyroid.
Although previous studies have returned mixed findings regarding the relationship between COVID-19 and thyroid function, an emerging body of evidence suggests a link between COVID-19 and autoimmune thyroid disorders. However, the association between long-term risk for thyroid dysfunction and COVID-19 infection remains unclear.
To assess the risk for thyroid dysfunction during a 1-year period following COVID-19 infection, researchers from ..read more
Endocrinology Advisor
4h ago
Sodium-glucose cotransporter-2 (SGLT-2) inhibitor use is associated with a reduced risk for atrial fibrillation (AF) regardless of diabetes duration, body mass index (BMI), and cardiovascular comorbidities among patients, but especially women, with type 2 diabetes, according to study results published in Cardiovascular Pharmacotherapy.
A growing body of evidence suggests that SGLT-2 inhibitors yield cardiovascular benefits independent of their glycemic-lowering effect. When comparing the cardioprotective effects of SGLT-2 inhibitors with other second- and third-line antidiabetic drugs, however ..read more
Endocrinology Advisor
4h ago
HealthDay News — Patients with untreated and new-onset hypertension have an increased risk for newly reported fibroid diagnosis, according to a study published online April 16 in JAMA Network Open.
Susanna D. Mitro, Ph.D., from Kaiser Permanente Northern California in Oakland, and colleagues examined associations of hypertension, antihypertensive treatment, anthropometry, and blood biomarkers with the incidence of reported fibroid diagnosis in midlife using data from the Study of Women’s Health Across the Nation. Participants were enrolled in 1996 to 1997 and followed through 13 semiannual vis ..read more
Endocrinology Advisor
4h ago
HealthDay News — Use of menopausal hormone therapy beyond age 65 years is associated with risk reductions in mortality as well as specific cancers and cardiovascular diseases, according to a study published online April 9 in Menopause.
Seo H. Baik, Ph.D., from the U.S. National Institutes of Health in Bethesda, Maryland, and colleagues examined the effects of different preparations of menopausal hormone therapy on all-cause mortality, five cancers, six cardiovascular diseases, and dementia using data for 10 million senior Medicare women.
The researchers found that the use of estrogen mono ..read more
Endocrinology Advisor
4h ago
Breathlessness in middle-aged adults is more common in women and is associated with obesity, respiratory disease, ongoing stress, depression, cardiac disease, and anemia, according to study findings published in Respiratory Research.
Researchers evaluated which medical conditions were associated with breathlessness in a population of middle-aged adults by conducting a population-based, cross-sectional analysis of the Swedish CArdioPulmonary bioImage Study (SCAPIS), which enrolled individuals aged 50 to 64 years from 2013 to 2018 at 6 centers.
Breathlessness, defined as a self-rated modifi ..read more
Endocrinology Advisor
4h ago
Coffee consumption may decrease the risk for gout by increasing levels of sex hormone-binding globulin (SHBG) and decreasing levels of urate and urea in the plasma, according to study results published in Clinical Rheumatology.
Researchers in China conducted a Mendelian randomization (MR) study to identify which components of diet affect gout risk and to identify the metabolites that mediate the effects of these dietary components. Data were obtained from the Integrative Epidemiology Unit Open Genome-Wide Association Studies summary datasets and included almost 10 million single nucleotide pol ..read more
Endocrinology Advisor
4h ago
The percentage of patients hospitalized with COVID-19 who receive supplemental home oxygen post discharge has changed little since early in the pandemic, despite evidence-based strategies for reducing home oxygen use in these patients, according to study findings published in Respiratory Care.
Investigators sought to estimate the proportion of oxygen-naïve patients hospitalized with COVID-19 who were subsequently discharged on home oxygen after September 2020. They also sought to characterize patient characteristics and treatments associated with home-oxygen initiation following discharg ..read more
Endocrinology Advisor
4h ago
Severe COVID-19 breakthrough infections were found among patients with idiopathic inflammatory myopathies (IIMs), with age and immunosuppressive treatment correlated with the risk for such infections, according to study findings published in Rheumatology.
Breakthrough COVID-19 infections suggest vaccine immunity may wane over time, though these infections are generally less severe than prevaccination cases. However, patients with autoimmune rheumatic diseases — especially individuals with IIMs — face heightened risks for severe outcomes from breakthrough infections, highlighting the need for f ..read more
Endocrinology Advisor
1d ago
Although uncommon, pregnancy among patients with Turner syndrome is increasing in the United States and associated with high-risk pregnancy outcomes, according to study findings published in Fertility and Sterility.
Turner syndrome, or the partial or complete loss of an X chromosome, occurs among 1 in every 2500 female births. Because as many as 50% of women with Turner syndrome have congenital heart defects, pregnancy has historically been discouraged. However, recent, less restrictive recommendations will likely result in an increasing number of patients with Turner syndrome pursuing pregnan ..read more
Endocrinology Advisor
1d ago
HealthDay News — Americans are facing more shortages of the drugs they need for medical care than ever before, a national pharmacy database shows.
The American Society of Health-System Pharmacists (ASHSP) and the University of Utah Drug Information Service started tracking drug shortages as far back as 2001.
Their latest data shows that things haven’t been this bad in all the years they’ve kept records.
A record high of 323 different meds were in short supply during the first quarter of 2024, the groups found. That’s worse than the last peak for drug shortages — 320 in 2014, according to ..read more